A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Myasthenia Gravis, Generalized

In brief

The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).

Key facts

Study ID
NCT07501702
Run by
Vertex Pharmaceuticals Incorporated
People needed
30
Starts
2026-05-13
Expected to finish
2029-03-02
Last updated by the study team
2026-08-03

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.